Sutskever Testifies in Musk vs. OpenAI Trial, Reveals $7 Billion Stake and Details of Altman Ouster

Ilya Sutskever, OpenAI's former chief scientist and co-founder, testified Monday in the ongoing Musk v. OpenAI trial, disclosing for the first time his approximately $7 billion ownership stake in the company's for-profit arm and providing testimony about his role in the November 2023 board coup that temporarily ousted CEO Sam Altman.

The hour-long testimony offered the most detailed public account to date of the internal dynamics that led to Altman's brief removal, including Sutskever's year-long effort to document what he characterized as Altman's pattern of deception. Sutskever also revealed that he declined a $6 million annual compensation package from Google to join OpenAI, underscoring the financial stakes that have emerged as the AI company's valuation reached $850 billion.

The November Coup and Its Aftermath

Sutskever's testimony centered on his participation in the board action that removed Altman as CEO in November 2023, an event that triggered a company-wide revolt and Altman's reinstatement within days. According to court records, Sutskever spent approximately a year gathering evidence of what he described as Altman's dishonesty, working with other board members to compile a case for the CEO's removal.

The former chief scientist helped draft a memo to the OpenAI board during the ouster attempt, a document that has become central to Musk's lawsuit against the company. A court order required Sutskever to produce this "Brockman memo" to plaintiffs, though the specific contents have not been made public.

Sutskever testified that he has remained estranged from both Altman and co-founder Greg Brockman since the failed coup attempt. The rift became permanent when Sutskever left OpenAI in 2024 and subsequently launched a competing AI laboratory, marking a complete break with his former colleagues.

Notably, Sutskever revealed that he avoided looking at the internet over the weekend following Altman's firing, suggesting the intense public and industry backlash to the board's decision caught participants off guard.

Financial Stakes and Strategic Context

The testimony revealed the enormous financial stakes involved in OpenAI's evolution from nonprofit research organization to commercial AI leader. Sutskever's $7 billion stake represents a significant portion of the company's $850 billion valuation, while co-founder Greg Brockman holds approximately $30 billion worth of OpenAI shares.

These revelations provide context for Musk's central legal argument that OpenAI has abandoned its founding mission as a nonprofit AI safety organization in favor of commercial profits. The financial incentives facing key executives and board members have become a focal point in the case, with Musk's team arguing that such stakes compromise the company's stated commitment to developing AI for humanity's benefit.

Sutskever's decision to decline Google's $6 million annual offer to join OpenAI also highlights the early financial calculations that shaped the company's formation, when equity stakes rather than immediate compensation proved the more lucrative path.

Safety Research and Superalignment

The testimony touched on Sutskever's leadership of OpenAI's superalignment team, which focused on ensuring the safety of future AI models. This research initiative, disbanded in May 2024 shortly after Sutskever's departure, represented one of the company's most visible commitments to AI safety research.

The dissolution of the superalignment team has become another point of contention in evaluating OpenAI's commitment to its founding principles. Sutskever's departure and the subsequent elimination of the program he led suggests a strategic shift away from the safety-first research approach that initially defined OpenAI's mission.

Trial Dynamics and Legal Strategy

Musk's legal team attempted unsuccessfully to treat Sutskever as a hostile witness, indicating they viewed his testimony as potentially damaging to their case despite his role in the Altman ouster. This legal maneuvering suggests complex allegiances and motivations among former OpenAI leadership that don't align neatly with the lawsuit's narrative.

The trial, presided over by US District Judge Yvonne Gonzalez Rogers, has featured testimony from other high-profile technology executives, including Microsoft CEO Satya Nadella and OpenAI Chairman Bret Taylor. Former OpenAI executives Greg Brockman, Mira Murati, and Shivon Zilis have also provided testimony, creating a comprehensive record of the company's internal dynamics and strategic evolution.

Looking at the broader implications, this case represents more than a dispute between former collaborators. The trial is establishing legal precedent for how nonprofit organizations can transition to commercial entities while maintaining their stated missions, a question that extends well beyond OpenAI to other technology companies with similar structures.

We have seen this pattern before, when other transformative technology companies faced scrutiny over their evolution from idealistic startups to commercial giants. The difference here lies in the stakes: artificial general intelligence development carries implications that extend far beyond typical commercial disputes, making questions of governance, mission alignment, and financial incentives matters of broader public interest.

The testimony also revealed the personal costs of OpenAI's internal conflicts, with former collaborators now operating as competitors and court witnesses. Sutskever's competing AI laboratory represents not just a business rivalry but a fundamental disagreement about the direction of AI development and safety research.

Analysis: Beyond the Courtroom

The financial revelations from Sutskever's testimony illuminate the extraordinary value creation that has occurred as OpenAI evolved from research nonprofit to commercial leader. The scale of individual stakes—billions of dollars for key figures—creates incentive structures that inevitably influence strategic decisions about AI development priorities and safety research commitments.

The disbanding of the superalignment team shortly after Sutskever's departure suggests that safety research, however well-intentioned, became difficult to sustain within the commercial pressures facing the company. This tension between research ideals and market realities appears central to Musk's legal arguments about OpenAI's departure from its founding mission.

The case continues to unfold, but Sutskever's testimony has provided the most detailed public account yet of the internal dynamics that transformed one of the most important AI research organizations into a commercial entity valued at nearly a trillion dollars. The implications extend well beyond this particular lawsuit to fundamental questions about AI governance and the structures needed to ensure advanced AI development serves broader human interests.